Access cutting-edge myeloablative allogeneic hematopoietic cell transplantation treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Boston location
Preparing your pre-screening questions…
Access myeloablative allogeneic hematopoietic cell transplantation specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myeloablative allogeneic hematopoietic cell transplantation treatment provided free
Check if you qualify for this myeloablative allogeneic hematopoietic cell transplantation clinical trial in Boston, MA
No-Cost Study Care
Local to Boston
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a single center pilot study evaluating intraoral photobiomodulation for the prevention of oral mucositis in patients undergoing myeloablative allogeneic hematopoietic cell transplantation (alloHCT). Patients who are planned for alloHCT will receive daily intraoral photobiomodulation therapy (PBMT) using a novel LED device. The name of the study device involved in this study is: \- THOR LX2.3 with LED Lollipop
Sponsor: Dana-Farber Cancer Institute
Yes, this clinical trial (NCT05335434) has an active research site in Boston, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for myeloablative allogeneic hematopoietic cell transplantation treatment options in Boston, MA, this clinical trial (NCT05335434) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myeloablative allogeneic hematopoietic cell transplantation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all myeloablative allogeneic hematopoietic cell transplantation clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Boston — not just this study.
Browse Leukemia Trials in Boston →